Author:
Jodrell D I,Bowman A,Rye R,Byrne B,Boddy A,Rafi I,Taylor G A,Johnston A,Clendeninn N J
Publisher
Springer Science and Business Media LLC
Reference18 articles.
1. Appelt, K., Bacquet, R. J., Bartlett, C. A., Booth, C. L., Freer, S. T., Fuhry, M. A., Gehring, M. R., Herrmann, S. M., Howland, E. F. & Janson, C. A. (1991). Design of enzyme inhibitors using iterative protein crystallographic analysis. J Med Chem 34: 1925–1934.
2. Bassendine, M. F., Curtin, N. J., Loose, H., Harris, A. L. & James, O. J. W. (1987). Induction of remission in hepatocellular carcinoma with a new thymidylate synthase inhibitor, CB3717. J Hepatol 4: 349
3. Calvert, A. H., Alison, D. L., Harland, S. J., Robinson, B. A., Jackman, A. L., Jones, T. R., Newell, D. R., Siddik, Z. H., Wiltshaw, E. & McElwain, T. J. (1986). A phase I evaluation of the quinazoline antifolate thymidylate synthase inhibitor, N10-propargyl-5,8-dideazafolic acid, CB3717. J Clin Oncol 4: 1245–1252.
4. Calvert, A. H., Newell, D. R., Jackman, A. L., Gumbrell, L. A., Sikora, E., Grzelakowska-Sztabert, B., Bishop, J. A., Judson, I. R., Harland, S. J. & Harrap, K. R. (1987). Recent preclinical and clinical studies with the thymidylate synthase inhibitor N10-propargyl-5,8-dideazafolic acid (CB 3717). NCI Monogr, 213–218.
5. Cantwell, B. M., Macaulay, V., Harris, A. L., Kaye, S. B., Smith, I. E., Milsted, R. A. & Calvert, A. H. (1988). Phase II study of the antifolate N10-propargyl-5,8-dideazafolic acid (CB 3717) in advanced breast cancer. Eur J Cancer Clin Oncol 24: 733–736.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献